METAHYDRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metahydrin, and what generic alternatives are available?
Metahydrin is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in METAHYDRIN is trichlormethiazide. There is one drug master file entry for this compound. Additional details are available on the trichlormethiazide profile page.
Summary for METAHYDRIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METAHYDRIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for METAHYDRIN
US Patents and Regulatory Information for METAHYDRIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | METAHYDRIN | trichlormethiazide | TABLET;ORAL | 012594-001 | Jun 16, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | METAHYDRIN | trichlormethiazide | TABLET;ORAL | 012594-002 | Jun 16, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |